Cancer Diagnostics – News and Features

Contact lenses that can capture and detect exosomes – vesicles with the potential to act as cancer biomarkers – could be used to screen for cancers.

A 3D tumor model around the size of a pencil eraser could help treat glioblastoma with personalized therapies by accurately replicating the tumor microenvironment.

University of Bristol research could lead to better detection of the most common type of malignant brain cancer.

Researchers have developed a new blood test that provides unprecedented insight into a patient’s cancer make-up, potentially allowing doctors to better select treatment options that will improve outcomes.

A new study has shown that a key genetic mutation that occurs early on in cancer alters RNA “dark matter” and causes the release of previously unknown RNA biomarkers.

UCF researchers have found a new way to track metastatic cancer cells in the body, which in the future could help identify cancer earlier and give patients more treatment options.

The liquid biopsy test, which uses two circulating proteins, was found to be highly accurate, sensitive and specific for both NASH and liver fibrosis.

Researchers have identified biomarkers for clear cell renal cell carcinoma and have developed a tool to indicate which patients are at high risk of poor outcomes.

Researchers have developed a novel, automated liquid biopsy test prototype, designed to detect cancer DNA in the blood of patients with advanced metastatic breast cancer within five hours.

Researchers have developed a nanophotonic-microfluidic sensor that has potential applications in cancer detection, monitoring and treatment response assessment.